Poor response to azithromycin in cutaneous leishmaniasis leading to a premature interruption of a multicentric phase III clinical trial in Brazil

Introduction Parenteral antimony-based compounds are still the standard of care for cutaneous leishmaniasis (CL) treatment in many countries, despite their high toxicity. Previous studies showed that oral azithromycin...

Full description

Main Authors: Toledo Junior, Antonio, Daher, André Bastos, Amaral, Thaís Alves, Carvalho, Sílvio Fernando Guimarães, Romero, Gustavo Adolfo Sierra, Rabello, Ana
Format: Artigo
Language: English
Published: Sociedade Brasileira de Medicina Tropical - SBMT 2017
Subjects:
Online Access: http://repositorio.unb.br/handle/10482/29128
https://dx.doi.org/10.1590/0037-8682-0266-2014
Tags: Add Tag
No Tags, Be the first to tag this record!